Spearhead Capital Advisors »

Kiniksa Pharmaceuticals shares owned by Spearhead Capital Advisors

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals shares owned by Spearhead Capital Advisors from 13F filings

Historical chart of Spearhead Capital Advisors investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Spearhead Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Spearhead Capital Advisors

Quarter filed Position value Share count Share price at filing
2022-09-30 $2.6M 203k 12.84
2022-06-30 $2.3M 235k 9.69
2022-03-31 $2.3M 235k 9.94
2021-12-31 $2.8M 235k 11.77
2021-09-30 $2.7M 235k 11.39
2021-06-30 $3.3M 235k 13.93
2021-03-31 $7.0M 377k 18.51
2020-12-31 $4.8M 270k 17.67
2020-09-30 $4.1M 270k 15.32
2020-06-30 $6.9M 271k 25.48
2020-03-31 $4.2M 271k 15.48

More positions owned by Spearhead Capital Advisors

Ishares Gold Tr Ishares New (IAU)
Microsoft Corporation (MSFT)
Ishares Core Msci Emkt (IEMG)
Apple (AAPL)
Kiniksa Pharmaceuticals Com Cl A
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Ishares Tr Rus 2000 Grw Etf (IWO)
Automatic Data Processing (ADP)
Visa Com Cl A (V)
Pepsi (PEP)
Adobe Systems Incorporated (ADBE)
Realty Income (O)

View all positions for Spearhead Capital Advisors

Top funds holding Kiniksa Pharmaceuticals

Harbor Capital Advisors
Birchview Capital

View all funds holding Kiniksa Pharmaceuticals